DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Amino Chemicals Ltd.
03 1Assia Chemical Industries Ltd - Teva Tech Site
04 1Everlight Chemical Industrial Corporation Kuanyin II Plant
05 1Glenmark Life Sciences Limited
06 1Indoco Remedies Limited
07 1MYLAN LABORATORIES LIMITED
08 2Maprimed S.A.
09 1Micro Labs Limited
10 1Viyash Life Sciences Private Limited
01 1RASAGILINE MESYLATE
02 1Rasagiline Base
03 6Rasagiline Mesylate
04 1Rasagiline mesylate
05 1rasagiline mesylate
06 1rasgiline mesylate
01 2Argentina
02 5India
03 1Israel
04 1Malta
05 1Taiwan
06 1U.S.A
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-900
Start Marketing Date : 2010-01-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66005-0029
Start Marketing Date : 2009-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63415-0518
Start Marketing Date : 2013-09-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65035-133
Start Marketing Date : 2013-06-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100g/100g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-878
Start Marketing Date : 2013-05-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14445-007
Start Marketing Date : 2013-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57741-1900
Start Marketing Date : 2006-05-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57741-2000
Start Marketing Date : 2006-05-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42571-280
Start Marketing Date : 2013-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-775
Start Marketing Date : 2015-02-19
End Marketing Date : 2026-12-01
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Rasagiline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rasagiline, including repackagers and relabelers. The FDA regulates Rasagiline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rasagiline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rasagiline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rasagiline supplier is an individual or a company that provides Rasagiline active pharmaceutical ingredient (API) or Rasagiline finished formulations upon request. The Rasagiline suppliers may include Rasagiline API manufacturers, exporters, distributors and traders.
click here to find a list of Rasagiline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rasagiline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rasagiline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rasagiline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rasagiline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rasagiline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rasagiline suppliers with NDC on PharmaCompass.
We have 10 companies offering Rasagiline
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
